YMI marketing campaign begins
Calgary, AB – TheNewswire – September 15, 2022 – nDatalyze Corp. (“NDAT“or the”society”) (CSE:NDAT) (OTC:NDATF) announces that the initial marketing campaign (“Campaign”) for its YMI advanced mental health platform has moved into the implementation stage. The campaign is focused on the pan-Canadian market and is expected to roll out over the next few months. The campaign was designed to test the effectiveness of a variety of marketing channels such as social media, search, display, video and native ads. Coinciding with the campaign, the Company will refine its benchmark programs involving both the consumer mobile health market and the “B2B” psychotherapist market. It is expected that initial revenues will be achieved before the end of the year before the refined release of YMI in the US market. The Campaign is fully funded by the Company’s existing cash balance.
NDAT President Jim Durward says, “With the YMI platform fully functional, marketing strategy defined, and mental health still a top concern for the general public, we believe this is a storyline.” in the right place at the right time. “Now is the time to execute.”
YMI is now available at https://ymihealth.ca/
About nDatalyze Corp. :
nDatalyze Corp. generates health-related technology solutionstions. The YMI division develops an online consumer mental health application based on machine learning with its Database Licensing division which focuses on providing a specialized health reference database to software developers. applications and researchers. YMI is based on the company’s proprietary reference database consisting of over 1200 complete biometric records with associated electroencephalogram (“EEG”) The data. With facilities around the world, its Medxtractor division manufactures small-scale bio-extractors that are used to extract compounds from a variety of botanical biomasses. While the Medxtractor division is currently generating cash flow, YMI is in development and therefore the Company cannot accurately predict if or when this application will become a cash flow generator.
FOR MORE INFORMATION, PLEASE CONTACT:
nDatalyze Corp.
James Durward, President and CEO
Phone: (403) 689-3901
E-mail: jimd@ndatalyze.com Website: www.ndatalyze.com
Investor Relations
RBMG – RB Milestone Group LLC
ndatalyze@rbmilestone.com
Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release. This press release does not constitute an offer to sell or a solicitation of an offer to sell any securities in the United States. The Securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the “United States Securities Act”) or any state securities law and may not be offered or sold in the United States or to US persons unless registered under United States securities law and applicable state securities laws or an exemption from such registration is available.
The information in this press release includes certain information and statements about management’s view of future events, expectations, plans and prospects that constitute forward-looking statements. These statements are based on assumptions subject to significant risks and uncertainties. Due to these risks and uncertainties and due to various factors, actual results, expectations, achievements or performance may differ materially from those anticipated and indicated by these forward-looking statements. A number of factors could cause actual results to differ materially from these forward-looking statements and from future results. Although the Company believes that the expectations reflected in the forward-looking statements are reasonable, it cannot guarantee that the expectations in the forward-looking statements will prove to be correct. Except as required by law, the Company disclaims any intention and undertakes no obligation to update or revise forward-looking statements to reflect actual results, whether as a result of new information, future events, changes in assumptions, changes in factors affecting these forward-looking statements or otherwise.
